Studies of Neuregulin/ERBB Signaling in Human Heart

Description

This study examines the role of the epidermal growth factor (EGF) receptor family and the EGF family of ligands in the regulation of non-myocytes isolated from the human heart.

Conditions

Heart Disease, Vascular Disease, Heart Failure

Talk to us

Study Overview

On this page

Study Details

Study overview

This study examines the role of the epidermal growth factor (EGF) receptor family and the EGF family of ligands in the regulation of non-myocytes isolated from the human heart.

Isolation and Characterization of ERBB Expressing Human Heart Progenitor Cells

Studies of Neuregulin/ERBB Signaling in Human Heart

Condition
Heart Disease
Intervention / Treatment

-

Contacts and Locations

Portland

Maine Medical Center, Portland, Maine, United States, 04102

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Clinical diagnosis of severe coronary artery disease scheduled to undergo coronary artery bypass surgery.
  • * less than 18 years of age
  • * unwilling or unable to provide informed consent
  • * known active myocarditis
  • * hypertrophic cardiomyopathy
  • * constrictive pericarditis or other significant pericardial disease
  • * severe pulmonary hypertension
  • * significant renal impairment (Cr \> 2.5 mg/dL)
  • * severe ventricular arrhythmias
  • * pregnancy

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Douglas B. Sawyer,

Study Record Dates

2026-06